1. 4,4-diphenyl-1-tert-butylpiperidine Hydrochloride
2. Budipine
3. Parkinsan
1. 63661-61-0
2. Parkinsan
3. Budipine (hydrochloride)
4. Nbf4q9307q
5. 1-tert-butyl-4,4-diphenylpiperidinium Chloride
6. Budipine Hcl
7. 1-tert-butyl-4,4-diphenylpiperidine;hydrochloride
8. Unii-nbf4q9307q
9. Parkinsan (tn)
10. Einecs 264-388-5
11. 1-tert-butyl-4,4-diphenylpiperidine Hydrochloride
12. Schembl1506558
13. Niosh/tm5031200
14. Budipine Hydrochloride [mi]
15. By-701
16. Budipine Hydrochloride [who-dd]
17. Tm50312000
18. D07589
19. 1-t-butyl-4,4-di-phenyl-piperidine-hydrochloride
20. Q27284776
21. Piperidine, 1-tert-butyl-4,4-diphenyl-, Hydrochloride
Molecular Weight | 329.9 g/mol |
---|---|
Molecular Formula | C21H28ClN |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 3 |
Exact Mass | 329.1910276 g/mol |
Monoisotopic Mass | 329.1910276 g/mol |
Topological Polar Surface Area | 3.2 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 313 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antiparkinson Agents
Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)